Le Lézard
Classified in: Health
Subjects: NPT, SVY, PSF

Tobacco Transformation Index Finds Most of the 15 Largest Tobacco Companies are Failing to Advance Harm Reduction


NEW YORK, Sept. 21, 2020 /PRNewswire/ -- The first Tobacco Transformation Index, released today and made possible with funding from the Foundation for a Smoke-Free World, finds that most of the 15 largest tobacco companies are not making substantive progress in phasing out cigarettes and other high-risk tobacco products and transitioning smokers to reduced-risk alternatives. A small group of companies have made public commitments to harm reduction and backed them with significant investments. A majority of companies have made no such commitment to tobacco harm reduction. With 1.3 billion tobacco users in the world, of which 8 million die annually from tobacco-related diseases, the stakes for global health are high. Adult cessation and tobacco harm reduction could reduce deaths within the next two decades.

The Tobacco Transformation Index is the first index to rank the world's largest 15 tobacco companies (accounting for nearly 90% of global cigarette volume) on their relative performance, commitment, and transparency to deliver material progress in supporting tobacco harm reduction. The 2020 Index assesses tobacco companies' activities from 2017-2019 related to: strategy and management, product sales, capital allocation, product offer, marketing, and lobbying and advocacy.

The 2020 Tobacco Transformation Index ranks Swedish Match, which divested its cigarette business in 1999, in first position. Phillip Morris International, British American Tobacco, Altria, Imperial Brands, Japan Tobacco, KT&G, ITC Ltd., Swisher International, Tobacco Authority of Thailand, Vietnam National Tobacco, Gudang Garam, Djarum, Eastern Co., and China National Tobacco Corp. follow Swedish Match in the overall rankings.

"Inspired by the success that indexes focusing on other sectors have demonstrated, the goal of the Tobacco Transformation Index is to stimulate external pressure and the industry competition needed to take combustion out of the cigarette market, accelerate change, and lower the unnecessary disease, death, and misery it causes so many people," said Dr. Derek Yach, President of The Foundation for a Smoke-Free World. "Society and large institutional investors such as banks and pension funds, which represent 85% of investment in publicly traded tobacco companies, have the leverage to push tobacco company management to drive measures that greatly improve health."

Industry Progress in Tobacco Harm Reduction is Not Sufficient

In 2019, 13 of the 15 tobacco companies in the Index generated at least 95% of net sales value through high-risk tobacco products including cigarettes. In 2019, Swedish Match's sales of reduced-risk products accounted for 44% of its net sales, followed by Philip Morris International at 19%, and British American Tobacco and KT&G at 5% each. Over the period of 2017-2019, eight of the 15 companies allocated 10% or less of research & development and capital investment expenditures to reduced-risk versus high-risk products.

During the Index's review period of 2017-2019, several companies, including British American Tobacco, Japan Tobacco, Philip Morris International, and KT&G Corp, made acquisitions of primarily cigarette businesses. These acquisitions were frequently focused on low-medium income countries (LMICs), where smoking rates are highest.

Among the six companies who made public commitments to harm reduction, between 30% and 55% of their marketing budgets were still devoted to high-risk products including cigarettes. "The tobacco companies are still spending a significant amount of their marketing budgets on high-risk products and, while a handful have increased their focus on youth access prevention, the impact of these policies is still unclear," said Dr. Yach.

Overall progress in reducing smoking and the use of toxic smokeless tobacco products globally remains frustratingly slow. To accelerate progress, new strategies and tools are needed to complement ongoing tobacco control efforts. A concerted effort to transform the global tobacco industry via a strategy of tobacco harm reduction could reduce users' current health risks and eventually help them to quit entirely.

State-Owned Tobacco Focused on Cigarette Sales

Nine of the world's 15 largest tobacco companies were found to have no active commitment to tobacco harm reduction and/or announced targets to increase the production and sales of high-risk tobacco products. Among this group, China National Tobacco Corp. (CNTC), Vietnam National Tobacco Corp., and the Tobacco Authority of Thailand are 100% government-owned enterprises. Other companies such as Eastern Tobacco Co. (51%), Japan Tobacco (33%), and ITC Ltd. (24%) have partial government stakes.  CNTC, the world's largest cigarette manufacturer and marketer, controls about 44% of global cigarette market share.

A new research report, "Contradictions and Conflicts," by international business and corporate governance scholar Daniel Malan, finds that nearly 50% of the global combustible cigarette market is controlled by World Health Organization Framework Convention on Tobacco Control (FCTC) signatory governments that also own tobacco companies. FCTC is designed to reduce supply and demand for tobacco and improve public health. Of the six companies with some degree of state ownership in the Index, five are in the lower half of the rankings. If state-owned tobacco companies were to embrace tobacco harm reduction, they could have significant impacts on the health of their citizens, while addressing long term fiduciary needs healthily.

Tobacco Companies Focusing Reduced-Risk Product Efforts on Higher-Income Countries

Companies that offer reduced-risk products are mostly targeting their efforts on selected high-medium income countries, where overall smoking rates are lower and cigarette sales are already declining. Three large multinationals ? British American Tobacco, Japan Tobacco, and Philip Morris International ? collectively offer reduced-risk products in 15 of the high-medium income countries in the 2020 Index scope of 36 countries. However, their reduced-risk alternatives reach just three low-medium income countries (LMICs).

"This first Tobacco Transformation Index reinforces that this industry is at the beginning of a long journey. True progress will come when we see all tobacco companies phase out their combustible cigarette businesses. For this to be possible, governments need to implement smarter regulations that support the transition, and WHO should actively support tobacco harm reduction. Bans, such as The Union's call to prohibit the sale of e-cigarettes and heated tobacco products in LMICs, are not the answer and only impede progress," said Dr. Yach.

The Tobacco Transformation Index was developed from 2019-2020 through a quantitative and qualitative research review conducted with grants received from the Foundation by consultants Euromonitor International, with guidance from an independent advisory panel and global stakeholder engagement program organized by advisory firm SustainAbility. The 2020 index is based on an assessment of 35 key indicators over the period 2017-2019. The analysis will be updated every two years. For more information visit www.tobaccotransformationindex.org.

The Foundation for a Smoke-Free World is an independent, US nonprofit 501(c)(3) private foundation with the mission of improving global health by ending smoking in this generation. The Foundation strives to achieve its mission by focusing its work on three core pillars: Health, Science, and Technology; the Agricultural Transformation Initiative; and Industry Transformation. The Foundation has received charitable contributions from PMI Global Services Inc. (PMI) in each of 2018 and 2019 in the amount of US $80 million. Under the Foundation's bylaws and its pledge agreement with PMI, Foundation shall maintain full independence, and shall make all its decisions on its own, free from the control, interim instructions, or influence from or by PMI or any other third parties. The Foundation's acceptance of any charitable contribution from PMI does not constitute an endorsement by the Foundation of any of PMI's products. For more information about the Foundation, please visit www.smokefreeworld.org.

For Media:
Nicole Bradley
Vice President of Communications
[email protected]

SOURCE The Foundation for a Smoke-Free World


These press releases may also interest you

at 09:15
Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today announced the appointment of two key executives, Jeron Evans as Chief Revenue...

at 09:10
BioSkryb Genomics, a company ushering in the next generation of single-cell technology, will highlight how its ResolveDNA and ResolveOME single-cell assays can unravel the complexities of tumor evolution at the American Association for Cancer...

at 09:07
KURU® Footwear, the inventor of heel-first footwear, today unveiled its 2024 Foot Pain Trends Report. Featuring significant industry discoveries and valuable consumer perspectives, KURU's comprehensive and medically reviewed report highlights the...

at 09:05
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that a podium talk and multiple abstracts featuring data for the company's NeXT Personal® whole genome-based, tumor-informed assay for ultra-sensitive ctDNA...

at 09:05
...

at 09:04
Canadian-based Noze, a global leader in the breath-based diagnostic space, announced today it received a new grant from the Bill & Melinda Gates Foundation, bringing the foundation's total grant funding to Noze to $1.8 million. The announcement comes...



News published on and distributed by: